452 related articles for article (PubMed ID: 27428710)
21. Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse.
Yamaguchi M; Ando M; Kato S; Katsuno T; Kato N; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S
J Rheumatol; 2015 Oct; 42(10):1853-60. PubMed ID: 26373560
[TBL] [Abstract][Full Text] [Related]
22. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
[TBL] [Abstract][Full Text] [Related]
23. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis.
Mohammad AJ; Segelmark M
J Rheumatol; 2014 Jul; 41(7):1366-73. PubMed ID: 24882836
[TBL] [Abstract][Full Text] [Related]
24. Peripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitis.
Unizony S; Lim N; Phippard DJ; Carey VJ; Miloslavsky EM; Tchao NK; Iklé D; Asare AL; Merkel PA; Monach PA; Seo P; St Clair EW; Langford CA; Spiera R; Hoffman GS; Kallenberg CG; Specks U; Stone JH
Arthritis Rheumatol; 2015 Feb; 67(2):535-44. PubMed ID: 25332071
[TBL] [Abstract][Full Text] [Related]
25. Proteinase 3-specific antineutrophil cytoplasmic antibody-associated vasculitis.
Falde SD; Fussner LA; Tazelaar HD; O'Brien EK; Lamprecht P; Konig MF; Specks U
Lancet Rheumatol; 2024 May; 6(5):e314-e327. PubMed ID: 38574742
[TBL] [Abstract][Full Text] [Related]
26. CD14 expression is increased on monocytes in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis and correlates with the expression of ANCA autoantigens.
Tarzi RM; Liu J; Schneiter S; Hill NR; Page TH; Cook HT; Pusey CD; Woollard KJ
Clin Exp Immunol; 2015 Jul; 181(1):65-75. PubMed ID: 25766482
[TBL] [Abstract][Full Text] [Related]
27. Predictive utility of ANCA positivity and antigen specificity in the assessment of kidney disease in paediatric-onset small vessel vasculitis.
Mann SK; Bone JN; Bosman ES; Cabral DA; Morishita KA; Brown KL;
RMD Open; 2024 Jun; 10(2):. PubMed ID: 38886004
[TBL] [Abstract][Full Text] [Related]
28. Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis.
McGregor JG; Hogan SL; Kotzen ES; Poulton CJ; Hu Y; Negrete-Lopez R; Kidd JM; Katsanos SL; Bunch DO; Nachman PH; Falk RJ
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1(Suppl 1):i123-31. PubMed ID: 25805743
[TBL] [Abstract][Full Text] [Related]
29. Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis.
Finkielman JD; Merkel PA; Schroeder D; Hoffman GS; Spiera R; St Clair EW; Davis JC; McCune WJ; Lears AK; Ytterberg SR; Hummel AM; Viss MA; Peikert T; Stone JH; Specks U;
Ann Intern Med; 2007 Nov; 147(9):611-9. PubMed ID: 17975183
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of remission induction therapy for ANCA-associated vasculitis in the elderly.
Aqeel F; Xu L; Salas A; Wen Y; Eid SM; Geetha D
Clin Rheumatol; 2023 Sep; 42(9):2427-2435. PubMed ID: 37225927
[TBL] [Abstract][Full Text] [Related]
31. Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis.
Alberici F; Smith RM; Jones RB; Roberts DM; Willcocks LC; Chaudhry A; Smith KG; Jayne DR
Rheumatology (Oxford); 2015 Jul; 54(7):1153-60. PubMed ID: 25477054
[TBL] [Abstract][Full Text] [Related]
32. Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts.
Pagnoux C; Hogan SL; Chin H; Jennette JC; Falk RJ; Guillevin L; Nachman PH
Arthritis Rheum; 2008 Sep; 58(9):2908-18. PubMed ID: 18759282
[TBL] [Abstract][Full Text] [Related]
33. Proteinase-3 antineutrophil cytoplasm antibody positivity in patients without primary systemic vasculitis.
McAdoo SP; Hall A; Levy J; Salama AD; Pusey CD
J Clin Rheumatol; 2012 Oct; 18(7):336-40. PubMed ID: 23047533
[TBL] [Abstract][Full Text] [Related]
34. A myelopoiesis gene signature during remission in anti-neutrophil cytoplasm antibody-associated vasculitis does not predict relapses but seems to reflect ongoing prednisolone therapy.
Kurz T; Weiner M; Skoglund C; Basnet S; Eriksson P; Segelmark M
Clin Exp Immunol; 2014 Feb; 175(2):215-26. PubMed ID: 24215168
[TBL] [Abstract][Full Text] [Related]
35. Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial.
Smith RM; Jones RB; Specks U; Bond S; Nodale M; Al-Jayyousi R; Andrews J; Bruchfeld A; Camilleri B; Carette S; Cheung CK; Derebail V; Doulton T; Ferraro A; Forbess L; Fujimoto S; Furuta S; Gewurz-Singer O; Harper L; Ito-Ihara T; Khalidi N; Klocke R; Koening C; Komagata Y; Langford C; Lanyon P; Luqmani R; McAlear C; Moreland LW; Mynard K; Nachman P; Pagnoux C; Peh CA; Pusey C; Ranganathan D; Rhee RL; Spiera R; Sreih AG; Tesar V; Walters G; Wroe C; Jayne D; Merkel PA;
Ann Rheum Dis; 2023 Jul; 82(7):937-944. PubMed ID: 36958796
[TBL] [Abstract][Full Text] [Related]
36. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
Csernok E; Lamprecht P; Gross WL
Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
[TBL] [Abstract][Full Text] [Related]
37. Urinary CD4 + T Cells Predict Renal Relapse in ANCA-Associated Vasculitis.
Prskalo L; Skopnik CM; Goerlich N; Freund P; Wagner L; Grothgar E; Mirkheshti P; Klocke J; Sonnemann J; Metzke D; Schneider U; Hiepe F; Eckardt KU; Salama AD; Bieringer M; Schreiber A; Enghard P
J Am Soc Nephrol; 2024 Apr; 35(4):483-494. PubMed ID: 38231590
[TBL] [Abstract][Full Text] [Related]
38. Changes in proteinase 3 anti-neutrophil cytoplasm autoantibody levels in early systemic granulomatosis with polyangiitis (Wegener's) may reflect treatment rather than disease activity.
Rasmussen N; Salmela A; Ekstrand A; de Groot K; Gregorini G; Cohen Tervaert JW; Gross WL; Wiik A; Jayne DR;
Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S38-44. PubMed ID: 23380137
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis.
Cornec D; Kabat BF; Mills JR; Cheu M; Hummel AM; Schroeder DR; Cascino MD; Brunetta P; Murray DL; Snyder MR; Fervenza F; Hoffman GS; Kallenberg CGM; Langford CA; Merkel PA; Monach PA; Seo P; Spiera RF; St Clair EW; Stone JH; Barnidge DR; Specks U
Rheumatology (Oxford); 2018 Apr; 57(4):639-650. PubMed ID: 29340623
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic accuracy of antineutrophil cytoplasmic antibodies (ANCA) in predicting relapses of ANCA-associated vasculitis: systematic review and meta-analysis.
Mehta P; Balakrishnan A; Phatak S; Pathak M; Ahmed S
Rheumatol Int; 2023 Mar; 43(3):437-448. PubMed ID: 36040492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
